These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9857912

  • 1. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
    Ronner E, Dykun Y, van den Brand MJ, van der Wieken LR, Simoons ML.
    Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912
    [No Abstract] [Full Text] [Related]

  • 2. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
    Batchelor WB, Tolleson TR, Huang Y, Larsen RL, Mantell RM, Dillard P, Davidian M, Zhang D, Cantor WJ, Sketch MH, Ohman EM, Zidar JP, Gretler D, DiBattiste PM, Tcheng JE, Califf RM, Harrington RA.
    Circulation; 2002 Sep 17; 106(12):1470-6. PubMed ID: 12234950
    [Abstract] [Full Text] [Related]

  • 3. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Bhatt DL, Topol EJ.
    JAMA; 2000 Sep 27; 284(12):1549-58. PubMed ID: 11000650
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists].
    Araujo R, Agustí A.
    Med Clin (Barc); 2000 Oct 07; 115(11):435-7. PubMed ID: 11093849
    [No Abstract] [Full Text] [Related]

  • 5. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.
    Herz; 2003 Aug 07; 28(5):393-403. PubMed ID: 12928738
    [Abstract] [Full Text] [Related]

  • 6. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA.
    Eur Heart J; 1998 Apr 07; 19 Suppl D():D10-21. PubMed ID: 9597518
    [Abstract] [Full Text] [Related]

  • 7. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Roe MT, Sapp SK, Lincoff AM.
    Cleve Clin J Med; 2000 Feb 07; 67(2):131-40. PubMed ID: 10680279
    [Abstract] [Full Text] [Related]

  • 8. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.
    Tcheng JE.
    Am Heart J; 1999 Oct 07; 138(4 Pt 2):261-2. PubMed ID: 10502231
    [No Abstract] [Full Text] [Related]

  • 9. [Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].
    Obradović S, Gligić B, Djordjević D, Jovicić A, Romanović R, Ratković N, Dincić D, Orozović V, Nikolić G.
    Vojnosanit Pregl; 2001 Oct 07; 58(1):65-72. PubMed ID: 11419288
    [No Abstract] [Full Text] [Related]

  • 10. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention.
    Boersma E, Akkerhuis KM, Théroux P, Califf RM, Topol EJ, Simoons ML.
    Circulation; 1999 Nov 16; 100(20):2045-8. PubMed ID: 10562258
    [Abstract] [Full Text] [Related]

  • 11. TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and percutaneous coronary intervention.
    Kandzari DE, Califf RM.
    Curr Opin Cardiol; 2002 Jul 16; 17(4):332-9. PubMed ID: 12151865
    [Abstract] [Full Text] [Related]

  • 12. Glycoprotein IIb-IIIa antagonists in non-ST elevation acute coronary syndromes and percutaneous interventions: from pharmacology to individual patient's therapy: part 1: the evidence of benefit.
    Zimarino M, De Caterina R.
    J Cardiovasc Pharmacol; 2004 Mar 16; 43(3):325-32. PubMed ID: 15076214
    [Abstract] [Full Text] [Related]

  • 13. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
    Berkowitz SD.
    Haemostasis; 2000 Mar 16; 30 Suppl 3():27-43. PubMed ID: 11182626
    [Abstract] [Full Text] [Related]

  • 14. Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention.
    Herrmann HC, Swierkosz TA, Kapoor S, Tardiff DC, DiBattiste PM, Hirshfeld JW, Klugherz BD, Kolansky DM, Magness K, Valettas N, Wilensky RL.
    Am J Cardiol; 2002 Jun 01; 89(11):1293-7. PubMed ID: 12031731
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
    Gurm HS, Tamhane U, Meier P, Grossman PM, Chetcuti S, Bates ER.
    Circ Cardiovasc Interv; 2009 Jun 01; 2(3):230-6. PubMed ID: 20031720
    [Abstract] [Full Text] [Related]

  • 16. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Kereiakes DJ, Broderick TM, Roth EM, Whang D, Shimshak T, Runyon JP, Hattemer C, Schneider J, Lacock P, Mueller M, Abbottsmith CW.
    Am J Cardiol; 1999 Aug 15; 84(4):391-5. PubMed ID: 10468074
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
    Sabatine MS, Jang IK.
    Am J Med; 2000 Aug 15; 109(3):224-37. PubMed ID: 10974186
    [Abstract] [Full Text] [Related]

  • 19. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
    Braunwald E, Maseri A, Armstrong PW, Califf RM, Gibler WB, Hamm CW, Simoons ML, Van de Werf F.
    Eur Heart J; 1998 Apr 15; 19 Suppl D():D22-30. PubMed ID: 9597519
    [Abstract] [Full Text] [Related]

  • 20. Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarction.
    Cannon CP.
    Clin Cardiol; 1999 Aug 15; 22(8 Suppl):IV30-6. PubMed ID: 10492851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.